News
Shortcuts from other journals
Hope is fading fast for torcetrapib
BMJ 2007; 334 doi: https://doi.org/10.1136/bmj.39170.502581.80 (Published 05 April 2007) Cite this as: BMJ 2007;334:716
Drugs that increase serum concentrations of high density lipoprotein should theoretically help prevent cardiovascular events such as heart attack. But hope is fading fast for the new drug torcetrapib, which increases concentrations of “good” cholesterol by inhibiting cholesterol ester transfer …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £173 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£38 / $45 / €42 (excludes VAT)
You can download a PDF version for your personal record.